Inhibition of IGF-IR leads to a slowdown in the growth of NB cells, including through phosphorylation and deactivation of N-MYC, is mediated by glycogen synthase kinase-3 β (GSK3β) [122]. The gene discussed is MYCN; the disease is neuroblastoma.